|
|
Volumn 27, Issue 1, 2011, Pages 99-104
|
|
Safety and pharmacokinetics of a novel lymphocyte function-associated antigen-1 antagonist ophthalmic solution (SAR 1118) in healthy adults
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AGENTS ACTING ON THE EYE;
ASPARTATE AMINOTRANSFERASE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
SAR 1118;
UNCLASSIFIED DRUG;
ABNORMAL EYE SENSATION;
ABNORMAL SENSATION;
ADULT;
ARTICLE;
ASTHENOPIA;
BLEPHAROSPASM;
BLURRED VISION;
CD3+ T LYMPHOCYTE;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CONSTIPATION;
DARK CIRCLE UNDER EYE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG DOSE ESCALATION;
DRUG ERUPTION;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRY EYE;
DYSGEUSIA;
EDEMA;
ERYTHEMA;
EVENING DOSAGE;
EYE DISCHARGE;
EYE DISEASE;
EYE IRRITATION;
EYE PAIN;
EYELID PAIN;
FEMALE;
HUMAN;
HUMAN EXPERIMENT;
HYPEREMIA;
INSOMNIA;
INTRAOCULAR PRESSURE;
LACRIMATION;
MALE;
MAXIMUM PLASMA CONCENTRATION;
MORNING DOSAGE;
MUSCULOSKELETAL PAIN;
NAUSEA;
NECK PAIN;
NORMAL HUMAN;
OCULAR HYPEREMIA;
OCULAR PRURITUS;
PAIN;
PAPULAR RASH;
PHASE 1 CLINICAL TRIAL;
PHOTOPHOBIA;
PRURITUS;
PUNCTATE KERATITIS;
RANDOMIZED CONTROLLED TRIAL;
SCHIRMER TEST;
SIDE EFFECT;
SKIN MANIFESTATION;
STOMATITIS;
TEAR FILM;
TEAR FILM BREAK UP TIME;
TIME TO MAXIMUM PLASMA CONCENTRATION;
VISUAL ACUITY;
ADOLESCENT;
ADULT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1;
MALE;
MIDDLE AGED;
OPHTHALMIC SOLUTIONS;
PROSPECTIVE STUDIES;
TEARS;
YOUNG ADULT;
|
|
EID: 79951997837
PISSN: 10807683
EISSN: None
Source Type: Journal
DOI: 10.1089/jop.2009.0105 Document Type: Article |
|
Times cited : (36)
|
|
References (9)
|
